Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema From Non-Cardiogenic Pulmonary Edema

NCT07338227 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT07338227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07338227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema From Non-Cardiogenic Pulmonary Edema
Lead sponsor
Beni-Suef University
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
January 1, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic pulmonary edema, clara cell protein, diagnostic biomarker, differentiation, non-cardiogenic pulmonary edema